Related references
Note: Only part of the references are listed.Advances in immunotherapeutic research for glioma therapy
Jeremy Tetsuo Miyauchi et al.
JOURNAL OF NEUROLOGY (2018)
Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha
Inan Olmez et al.
NEURO-ONCOLOGY (2018)
The possibility of cancer immune editing in gliomas. A critical review
Victor A. Arrieta et al.
ONCOIMMUNOLOGY (2018)
The Expression and Prognostic Impact of Immune Cytolytic Activity-Related Markers in Human Malignancies: A Comprehensive Meta-Analysis
Constantinos Roufas et al.
FRONTIERS IN ONCOLOGY (2018)
Mutant IDH1 regulates the tumor-associated immune system in gliomas
Nduka M. Amankulor et al.
GENES & DEVELOPMENT (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2017)
Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme
Giannis Sokratous et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: Clinical data to date, current limitations and perspectives
J. Gauthier et al.
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE (2017)
AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction
Chun-Wu Pan et al.
EMBO JOURNAL (2017)
Applications of Immunogenomics to Cancer
X. Shirley Liu et al.
CELL (2017)
Integrated genomic characterization of IDH1-mutant glioma malignant progression
Hanwen Bai et al.
NATURE GENETICS (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
CGCG clinical practice guidelines for the management of adult diffuse gliomas
Tao Jiang et al.
CANCER LETTERS (2016)
Bioinformatic profiling identifies an immune-related risk signature for glioblastoma
Wen Cheng et al.
NEUROLOGY (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Anatomical Involvement of the Subventricular Zone Predicts Poor Survival Outcome in Low-Grade Astrocytomas
Shuai Liu et al.
PLOS ONE (2016)
Genetic variations of MUC17 are associated with endometriosis development and related infertility
Ching-Wen Yang et al.
BMC MEDICAL GENETICS (2015)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
Gregory L. Beatty et al.
CLINICAL CANCER RESEARCH (2015)
HMCN1, a cell polarity-related gene, is somatically mutated in gastric and colorectal cancers
Sung Hak Lee et al.
PATHOLOGY & ONCOLOGY RESEARCH (2015)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
Three missense mutations found in the KEL gene lead to Kmod or K0 red blood cell phenotypes
Antonella Matteocci et al.
TRANSFUSION (2014)
Architects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromes
Wangzhi Li et al.
EPIGENOMICS (2014)
The common hereditary elliptocytosis-associated α-spectrin L260P mutation perturbs erythrocyte membranes by stabilizing spectrin in the closed dimer conformation
Sandra L. Harper et al.
BLOOD (2013)
Understanding high grade glioma: Molecular mechanism, therapy and comprehensive management
Yongzhi Wang et al.
CANCER LETTERS (2013)
Relationship between Tumor Enhancement, Edema, IDH1 Mutational Status, MGMT Promoter Methylation, and Survival in Glioblastoma
J. A. Carrillo et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2012)
Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group
Wei Yan et al.
NEURO-ONCOLOGY (2012)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Structure and function of SWI/SNF chromatin remodeling complexes and mechanistic implications for transcription
Liling Tang et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2010)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
RV Parry et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice
BJ Johnson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
p53 dependent apoptosis in glioma cell lines in response to hydrogen peroxide induced oxidative stress
K Datta et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2002)
Identification, tissue specific expression, and chromosomal localisation of several human dynein heavy chain genes
AK Maiti et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2000)
Share Paper
